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Abstract
Metabolic versatility has been increasingly recognized as a major virulence mechanism that enables Mycobacterium
tuberculosis to persist in many microenvironments encountered in its host. Glucose is one of the most abundant carbon
sources that is exploited by many pathogenic bacteria in the human host. M. tuberculosis has an intact glycolytic pathway
that is highly conserved in all clinical isolates sequenced to date suggesting that glucose may represent a non-negligible
source of carbon and energy for this pathogen in vivo. Fructose-6-phosphate phosphorylation represents the key-
committing step in glycolysis and is catalyzed by a phosphofructokinase (PFK) activity. Two genes, pfkA and pfkB have been
annotated to encode putative PFK in M. tuberculosis. Here, we show that PFKA is the sole PFK enzyme in M. tuberculosis with
no functional redundancy with PFKB. PFKA is required for growth on glucose as sole carbon source. In co-metabolism
experiments, we report that disruption of the glycolytic pathway at the PFK step results in intracellular accumulation of
sugar-phosphates that correlated with significant impairment of the cell viability. Concomitantly, we found that the
presence of glucose is highly toxic for the long-term survival of hypoxic non-replicating mycobacteria, suggesting that
accumulation of glucose-derived toxic metabolites does occur in the absence of sustained aerobic respiration. The culture
medium traditionally used to study the physiology of hypoxic mycobacteria is supplemented with glucose. In this medium,
M. tuberculosis can survive for only 7–10 days in a true non-replicating state before death is observed. By omitting glucose in
the medium this period could be extended for up to at least 40 days without significant viability loss. Therefore, our study
suggests that glycolysis leads to accumulation of glucose-derived toxic metabolites that limits long-term survival of hypoxic
mycobacteria. Such toxic effect is exacerbated when the glycolytic pathway is disrupted at the PKF step.
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Introduction
Despite the availability of effective anti-tubercular drugs,
tuberculosis (TB) remains a scourge of public health with 8.8
million people infected with active TB in 2010 [1]. The metabolic
versatility of M. tuberculosis, the etiological agent of TB, represents
one of the key virulence strategies developed by the pathogen to
persist in many microenvironments within its host [2]. Earlier
studies on carbon metabolism have shown that M. tuberculosis can
utilize a variety of carbon substrates [3].
During infection, several studies have shown that the gluconeo-
genic pathway is required for infection and persistence, suggesting
that fatty acids constitute one of the main carbon and energy
source utilized by M. tuberculosis [4–7]. In addition, the sequencing
of M. tuberculosis genome revealed that fatty acid b-oxidation genes
are extensively duplicated [8] and are up-regulated during
infection in macrophages [9] and in mice [10]. Beside fatty acids,
host cholesterol is another possible carbon source used by M.
tuberculosis during infection [11,12].
However, M. tuberculosis displays a unique versatility for carbon
metabolism that we are only starting to appreciate and under-
stand. A recent study has shown that M. tuberculosis is not subjected
to catabolic repression and is therefore capable of co-catabolizing
several carbon sources simultaneously for optimal growth [13]. In
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particular, the simultaneous catabolism of glucose and lipids was
found to potentiate bacterial growth, at least in vitro [13].
Therefore, even though b-oxidation is required for virulence, it
is conceivable that other carbon and energy sources may be
utilized by M. tuberculosis for optimal infection and persistence in
the various microenvironments within its host. Glucose represents
one of the most abundant sources of carbon and energy, and it is
thus not surprising that the glycolytic pathway is highly conserved
in almost all living organisms. Indication that glucose metabolism
might be important for M. tuberculosis during infection arises from a
study where putative carbohydrate transporters and a hexose
kinase were found essential for infection in mice [10]. Studies in
Salmonella enterica serovar Typhimurium, an intracellular pathogen,
have also shown that glycolysis is required for infection [14,15].
The M. tuberculosis genome reveals an intact glycolytic and
pentose phosphate pathway but no Entner-Doudoroff pathway
[8]. Early in vitro studies suggested that glucose is predominantly
oxidized through glycolysis while a small fraction enters the
pentose phosphate pathway [16]. The key-committing step of
glycolysis is catalyzed by a phosphofructokinase (PFK) activity,
which irreversibly catalyzes the phosphorylation of fructose-6-
phosphate to fructose-1,6-bisphosphate (Fig. 1). Two putative
PFKs (PFKA and PFKB) encoding genes have been annotated in
M. tuberculosis genome, namely Rv3010c and Rv2029c, respectively.
Although both enzymes are proposed to catalyze the same
enzymatic reaction, they belong to different subfamilies; PFKA
belongs to the PFK protein family whereas PFKB belongs to the
pfkB subfamily of ribokinase superfamily. Furthermore, not only
their amino acid sequence greatly differs, but their gene
expressions are different whereby pfkB, is a member of the DOS
regulon and is up-regulated during hypoxia [17,18] and in
activated macrophages [9]. TraSH-based mutagenesis screen
indicated that both pfkA and pfkB are not essential for the survival
of M. tuberculosis in vitro and in vivo growth [10,19].
In this work, we investigated the role of PFKA and PFKB in M.
tuberculosis glucose metabolism. We demonstrated that pfkA encodes
a functional PFK that is essential for growth on glucose as sole
carbon source, and is responsible for the total PFK activity in M.
tuberculosis. No functional redundancy between pfkA and pfkB could
be established. Our data indicate that a functional glycolytic
pathway is required to limit the intracellular accumulation of
glucose-derived toxic metabolic intermediates during co-metabo-
lism. We also report a strong detrimental effect of glucose




All the animal experiments were approved by and carried out
under the guidelines of the Institutional Animal Care and Use
Committee (IACUC) of Novartis Institute for Tropical Diseases,
Singapore. Non-terminal procedures were performed under
anesthesia, and all efforts were made to minimize suffering.
Mycobacterial strains and growth conditions
M. tuberculosis H37Rv and derivative mutant strains were grown
in Middlebrook 7H9 liquid medium supplemented with 0.2%
glycerol, 0.5% bovine serum albumin fraction V, 0.2% glucose,
0.085% sodium chloride and 0.05% Tween-80 or on Middlebrook
7H11 agar supplemented with 10% oleic acid-dextrose-albumin-
catalase enrichment and 0.5% glycerol. When required, culture
media were supplemented with hygromycin at final concentration
of 80 mg/ml or with kanamycin at a final concentration of 25 mg/
ml.
For growth kinetics studies in defined culture broth media,
mycobacteria were first cultured in 7H9 medium until mid-log
phase, washed once with defined culture broth medium (no carbon
source) and then inoculated at an initial optical density at 600 nm
(OD600) of 0.05. The defined culture broth media contained 2.5 g
Na2HPO4, 1 g KH2PO4, 0.424 g glutamic acid, 1 mg pyridoxine,
0.5 mg biotin, 15 mg ferric ammonium citrate, 40 g MgSO4,
0.5 mg CaCl2, 0.6 mg ZnSO4, 0.6 mg CuSO4, 0.8 g NaCl, 0.5 g
Tyloxapol and 0.1% fatty-acid free bovine serum albumin (Sigma
A8806) per litre of medium. Glucose, acetate or glycerol was
added at a final concentration of 0.2% as carbon source. Bacterial
growth was monitored by measuring the optical density at 600 nm
over time.
For growth kinetics studies in Dubos medium, mycobacteria
were first culture in Dubos liquid medium (Difco) supplemented
with 0.5% BSA fraction V, 0.085% NaCl and 0.03% Tween-80
until mid-log phase. The cells were inoculated at an initial OD600
of 0.05 in either Dubos liquid medium described previously or in
complete Dubos liquid medium (further supplemented with 0.75%
glucose). Bacterial growth was monitored at OD600 over time.
Construction of M. tuberculosis knockout and
complemented strains
The knockout mutants were obtained by double homologous
recombination using plasmid pYUB854 as described before [20].
Briefly, fragments of ,1 kb flanking pfkA or pfkB opening reading
Figure 1. Schematic representation of the glycolytic pathway.
Key committing step of glycolysis is catalyzed by pfkA/pfkB.
doi:10.1371/journal.pone.0056037.g001
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frames (ORFs) were PCR amplified from H37Rv genomic DNA
using primer pairs: PFKA5F-PFKA5R, PFKA3F-PFKA3R,
PFKB5F-PFKB5R and PFKB3F-PFKB3R (Table 1). The 59
and 39 flanking fragments were then cloned into pYUB854
flanking the hygromycin-resistance gene. The sacB-lacZ cassette
excised from pGOAL17 [21] was finally cloned into the unique
PacI site of pYUB854. The final plasmids were UV-irradiated
prior to electroporation into H37Rv strain. Positive clones of
knockout mutants were selected as white colonies on 7H11 agar
supplemented with hygromycin and X-Gal. Deletion of the target
gene was verified by PCR (primers sequence in Table 1) and
confirmed by Southern blot. Unmarked knockout mutant of pfkA
was obtained upon removal of the hygromycin cassette using the
resolvase gene-containing plasmid pWM19 as described previously
[22]. Colonies were first selected on 7H11 agar containing
gentamycin at 31uC and followed by selection on 7H11 agar
supplemented with 2% sucrose at 39uC.
For complementation of DpfkA mutant, the pfkA ORF and its
putative promoter region were PCR amplified with primers
PFKAcF and PFKAcR (Table 1) from H37Rv genomic DNA and
cloned into the promoterless integrative vector pMV306 [23]. For
complementation of DpfkB mutant, the pfkB ORF was PCR
amplified with primers PFKBcF and PFKBcR (Table 1) and
cloned into replicative vector pMV262 under the constitutive
hsp60 promoter [23]. The XbaI-HindIII fragment from recombi-
nant pMV262- hsp60pfkB plasmid was then cloned into pMV306,
giving pMV306-hsp60pfkB. All the complemented strains were
verified by PCR.
Southern blot analysis of knockout mutants
Genomic DNA of the parental and mutant strains were digested
with restriction enzyme BamHI for confirmation of pfkA deletion
and EcoRI for confirmation of pfkB deletion. Digested DNA was
separated on a 0.8% agarose gel, transferred onto nylon
membrane and probed for modification of the loci. Southern blot
analysis was performed using DIG Nonradioactive Nucleic Acid
Labelling and Detection System (Roche), following the manufac-
turer’s instruction. DIG-labelled probeA and probeB (Fig. 2) were
PCR-amplified using primer pairs of PFKAusF-PFKAsR and
Table 1. Primers used in this study.
Primer Sequence (59-39) Purpose
PFKA5F CGACTAGTCGCGCTGACCGCGACCGTCG pfkA knockout
PFKA5R TACCATGGGTACGCACCACCGCACGGATG pfkA knockout
PFKA3F GTTCTAGAAGATGGTGACGTTGCGCGGC pfkA knockout
PFKA3R CACTTAAGGTGTAACCGGCCTCGTGAAAG pfkA knockout
PFKB5F CGACTAGTCACGCAACCAGCGCTACGA pfkB knockout
PFKB5R TGCCATGGCAGTGATGTCGAGCAACCG pfkB knockout
PFKB3F GCTCTAGACGCGACGATGTGGAGAGGT pfkB knockout
PFKB3R CGCTTAAGCGCAACCGAAGCTGCGACA pfkB knockout
PFKAcF TATCTAGACCGCTACTGAGCGCCATTTA pfkA ORF
PFKAcR TAAAGCTTACCCGACGTCAACCGAAGAA pfkA ORF
PFKBcF TAAGATCTATGACGGAGCCAGCGGCGTG pfkB ORF
PFKBcR GCAAGCTTGTGTGATTGGTTCATGGCGA pfkB ORF
PFKA-pET29F TACATATGCGGATTGGAGTTCTTACCG Cloning into pET29a
PFKA-pET29R TACTCGAGACCGAAGAAGGCGGCGGC Cloning into pET29a
PFKB-pET15F TACATATGACGGAGCCAGCGGCGTG Cloning into pET15b
PFKB-pET15R TACTCGAGGTGTGATTGGTTCATGGCGAGG Cloning into pET15b
PFKA-pQE60F TACCATGGGTATGCGGATTGGAGTTCTTAC Cloning into pQE60
PFKA-pQE60R TAAGATCTACCGAAGAAGGCGGCGGC Cloning into pQE60
PFKAInF GGTCGGATTTCAGAACGGCTT Verification of pfkA deletion
PFKAInR CATGCCTACCCATCACCTCCA Verification of pfkA deletion
PFKBInF GAGCAATGCCTCGACGAACTG Verification of pfkB deletion
PFKBInR CTGCCGCGTTTCCCAAGCGA Verification of pfkB deletion
PFKAusF CGGCGTAAACCCACCTACG Verification of pfkA deletion
PFKAdsR GCGCGACAGGCTCCAAATCC Verification of pfkA deletion
PFKBusF CGCAACACCGTGGTCCGAGA Verification of pfkB deletion
PFKBdsR CTTCGACGATCTGTTCAATCC Verification of pfkB deletion
HygF CTTCACCGATCCGGAGGAACT Verification of gene deletion
HygR GACGACCTGCAGGCATGCAA Verification of gene deletion
PFKAsR ATTGCTCGACACCTCCGAGGG Southern blot probe
PFKBsR TTCCACGAGGTAACGCGTCC Southern blot probe
Restriction sites are underlined.
doi:10.1371/journal.pone.0056037.t001
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PFKBusF-PFKBsR (Table 1) respectively. Bands were visualized
using chemiluminescent detection.
Complementation of an E.coli PFK knockout mutant
Mycobacterial pfkA and pfkB ORFs were PCR amplified using
primer pairs PFKApQE60F-PFKApQE60R and PFKBcF-
PFKBcR respectively (Table 1). pfkA was cloned into expression
vector pQE-60 and and pfkB was cloned into pQE-30 (Qiagen).
These vectors allow an IPTG-inducible T5 promoter-driven
expression in E. coli. The recombinant plasmids were electropo-
rated into DpfkADpfkB E. coli mutant RL257 (CGSC, Yale) [24].
The transformed RL257 strains and control RL257 strain were
grown in Luria Bertani (Miller) broth medium (Difco) until mid-
log phase and washed once with M9 solution (Difco). OD600 was
then adjusted to 0.01 before streaking onto minimal medium agar
containing M9 minimal salts (Difco) supplemented with 2 mM
MgSO4 and 0.2% glucose or glycerol as carbon source. Expression
of mycobacterial pfkA and pfkB genes was induced by 0.01 mM
IPTG in the agar plates. Bacteria were incubated at 37uC
overnight.
Cloning, expression and purification of PFKA and PFKB
The pfkA and pfkB ORFs were PCR amplified from H37Rv
genomic DNA with primer pairs PFKApET29F-PFKApET29R
and PFKBpET15F-PFKBpET15R respectively (Table 1). pfkA was
cloned into expression vectors pET-29a(+) and pfkB was cloned
into pET15b (Novagen). pfkA was expressed as C-terminal 6xHis-
tag recombinant protein while pfkB was expressed as N-terminal
6xHis-tag recombinant protein in E. coli BL21(DE3) (Stratagene).
Bacteria cultures were grown at 37uC in LB broth until mid-log
phase and then transferred to 16uC. Induction of recombinant
protein expression started with the addition of 0.1 mM IPTG and
bacteria were cultured at 16uC for 20 hrs. Bacterial cells were
harvested and disrupted by sonication. Cell debris were removed
by centrifugation and the His-tagged proteins were purified under
native conditions on Ni-NTA agarose column (Qiagen) followed
by size exclusion chromatography on Superdex 200 10/300 GL
column (GE Healthcare). The proteins were stored at 280uC in
buffer containing 50 mM Tris-HCl pH7.5 and 5 mM MgCl2.
Preparation of cell-free crude extracts for enzyme and
metabolite assays
Cell-free crude extracts of M. tuberculosis strains were prepared
by harvesting mid-log phase culture grown in 7H9 medium. For
metabolites measurement, bacterial strains were culture in
complete Dubos liquid medium or Dubos liquid medium without
glucose. Mycobacterial cells were washed twice with PBS/0.05%
Tween-80 and resuspended in lysis buffer [50 mM Tris-HCl
pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol and complete
protease inhibitor (Roche)]. Mycobacterial cells were disrupted
mechanically by 0.1 mm glass beads in FastPrep FP220A bead-
beater (Qbiogen). Lysates were clarified by centrifugation and then
filtered through 0.22 mm filter. Total protein concentration was
measured with BCA protein assay reagent kit (Pierce). Cell-free
crude extracts to be used for metabolite assays were boiled for
10 min and centrifuged at 13,000 rpm for 10 min at 4uC.
Phosphofructokinase activity assay
Phosphofructokinase activity was measured in an enzyme-
coupled assay in which fructose-1,6-bisphophate formation is
coupled to the oxidation of NADH [25]. The standard assay
mixture (0.1 ml) contained 5 mM fructose-6-phosphate, 1 mM
ATP, 0.3 mM NADH (Roche), 1 unit each of aldolase, triosepho-
sphate isomerase and glycerol-3-phosphate dehydrogenase in
50 mM Tris-HCl pH7.5 and 5 mM MgCl2. For enzymatic assay
with purified recombinant proteins, 1 mM fructose-6-phosphate
and 0.1 mM ATP were used instead. The enzyme activities were
measured by monitoring the decrease in absorbance at 340 nm
using a SpectraMax spectophotometer (Molecular Devices) at
room temperature. Quantification was done with a NADH
Figure 2. Deletion of pfkA and pfkB genes in M. tuberculosis. Schematic representation of the genomic regions of (A) pfkA in WT and DpfkA
mutant, (C) pfkB in WT and DpfkB mutant, and location of restriction sites and probes. (B) and (D) are Southern blots confirming the knockout of pfkA
and pfkB genes respectively. res: sites of resolvase; hyg: hygromycin resistance cassette.
doi:10.1371/journal.pone.0056037.g002
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standard curve. All enzymes and reagents used in enzyme-coupled
assay were purchased from Sigma-Aldrich, unless otherwise stated.
Immunoblotting
Samples of cell-free crude extract were separated on a NuPAGE
4–12% polyacrylamide get (Invitrogen) and transferred to PVDF
membrane. PFKB was detected with rabbit polyclonal anti-PFKB
antibody, raised against the recombinant PFKB, and visualized
with SuperSignal West Pico Chemiluminescent Substrate kit
(Pierce). Ponseus-S (Sigma-Aldrich) staining of the membrane was
done to check for equal loading of the cell lysates.
Measurement of intracellular metabolites
Intracellular metabolites concentration were enzymatically
determined as described by Hasan et al [26] with slight
modifications. Glucose-6-phosphate concentration was deter-
mined by measuring the increase in absorbance at 340 nm in an
enzymatic assay reaction (0.2 ml) containing 0.3 mM NADP+
(Roche), 0.1 unit of glucose-6-phosphate dehydrogenase in
50 mM Tris-HCl pH7.5 and 5 mM MgCl2. To determine the
concentration of fructose-6-phosphate, 0.1 unit of phosphoglucose
isomerase was added to the reaction mixture after glucose-6-
phosphate reaction was completed and the change in absorbance
at 340 nm was recorded. Quantification was done with a NADPH
standard curve. All enzymes and reagents used in metabolites
measurement were purchased from Sigma-Aldrich, unless other-
wise stated.
Mouse infection
Animals were housed in specific pathogen-free conditions in
individual ventilated cages in an ABSL3 facility. Female BALB/c
mice of 6–8 weeks old were nasally infected with 103 CFU of
H37Rv parental and DpfkA strains. Four animals per group were
sacrificed at the indicated time points. The lungs and spleen were
aseptically harvested and homogenized in PBS/0.05% Triton X-
100. The bacterial load were quantified by plating serial dilutions
of the organ homogenates on 7H11 agar supplemented with
cycloheximide and ampicillin each at 10 mM. The number of
CFU was recorded after 16 days incubation at 37uC.
Wayne model of hypoxia
M. tuberculosis H37Rv and mutant strains were subjected to slow
withdrawal of oxygen as described before [27]. Mycobacteria were
first cultured in Dubos liquid medium (without glucose). The cells
were then diluted in either Dubos liquid medium (without glucose)
or complete Dubos liquid medium to a final OD600 of 0.002.
17 ml of the diluted culture was aliquoted into screw-cap test tubes
(20 mm by 125 mm) to maintain a head-to-space ration of 0.5 and
the test tubes were tightly capped. The cultures were then stirred
gently at 170 rpm on magnetic stirring platform at 37uC.
Methlylene blue (1.5 mg/ml) was added to two representative
tubes to monitor oxygen depletion. Growth and survival of
mycobacteria were determined by enumeration of CFU after 2 to
3 weeks of incubation at 37uC on 7H11 agar plated out at various
time-points..
Results
PfkA is responsible for the total PFK activity in M.
tuberculosis
Two genes pfkA (Rv3010c) and pfkB (Rv2029c) have been
annotated to encode a PFK in M. tuberculosis. To investigate the
relative contribution of each gene product to the overall M.
tuberculosis PFK activity, M. tuberculosis mutants deleted for either
pfkA or pfkB were constructed by homologous recombination in M.
tuberculosis H37Rv. Since pfkA is part of an operon, an unmarked
pfkA KO mutant was constructed to avoid any polar effect on
downstream open reading frame (ORF) gatB (Fig. 2). Deletion at
the correct genetic locus was confirmed by Southern blot (Fig. 2).
Complementation was then performed whereby an intact copy of
the pfkA ORF and its promoter region was re-introduced into the
DpfkA bacterial chromosome using the promoterless integrative
plasmid pMV306. A PFK enzymatic assay was developed using
cell-free extracts from the parental (WT), KO and complemented
strains. Results showed that PFK activity could not be detected
over background level in the DpfkA mutant (Table 2). The PFK
activity in DpfkB mutant was comparable to that measured in the
WT strain, suggesting that pfkB does not encode for a functional
PFK. The PFK activity could be restored to parental level in the
DpfkA mutant upon complementation with a wild-type copy of pfkA
(Table 2). These data thus suggested that pfkA is responsible for the
total PFK activity in M. tuberculosis, at least under aerobic
conditions.
Since pfkB was previously reported to be upregulated under
hypoxic condition and in activated macrophages [9], we
hypothesized that PFKB may contribute to M. tuberculosis PFK
activity under hypoxia but not during aerobic growth. To test
whether pfkB encodes for a functional PFK, the pfkB ORF was
cloned in a replicative plasmid (pMV262) under the control of the
constitutive hsp60 promoter, and expressed in the DpfkA mutant.
PFKB over-expression in the DpfkA mutant was confirmed by
Western blot (Fig. 3), but did not lead to detectable PFK activity
levels in the cell free extracts, further supporting that PFKB does
not contribute to the mycobacterial PFK activity (Table 2).
Consistently, when M. tuberculosis PFKA and PFKB were expressed
in a pfkA/pfkB double KO strain of E. coli (RL257) [24], only
mycobacterial pfkA but not pfkB allowed the growth of E. coli
RL257 on minimal medium with glucose as the sole carbon source
(Fig. 4), strongly suggesting that pfkB does not encode for a PFK
enzyme.
Finally, His-tagged PFKA and PFKB proteins were over-
expressed in E. coli, purified and tested in enzyme-coupled assay
for their PFK activity. PFKA was able to catalyze the phosphor-
ylation of fructose-6-phosphate to fructose-1,6-bisphosphate effi-
ciently, whereas no significant activity was detected from PFKB
(Table 2).
Taken together, these data strongly support that pfkA is
responsible for the overall PFK activity in M. tuberculosis H37Rv,
and that pfkB does not catalyze fructose-6-phosphate in vivo.
pfkA is necessary and sufficient for M. tuberculosis growth
on glucose as sole carbon source
To further study the role of pfkA and pfkB in mycobacterial
glucose metabolism, we tested the ability of both the DpfkA and
DpfkB mutants to grow in the presence of glucose as sole carbon
source. The results showed that DpfkA mutant was unable to grow
efficiently on glucose as sole carbon source whereas it displayed a
parental growth kinetic on acetate or glycerol (Fig. 5A–C). The
growth defect on glucose observed with mpfkA mutant was restored
upon complementation with a wild-type copy of pfkA (Fig. 5A).
Consistent with the PFK activity data (Table 2), the growth defect
of DpfkA mutant could not be reversed upon constitutive
expression of pfkB (Fig. 5A). In contrast, DpfkB mutant showed
no growth defect on glucose (Fig. 5D) which is in agreement with
the PFK activity measured in this mutant strain (Table 2). These
data thus further support that PFKA is indispensable for the
PFKA Is a Phosphofructokinase in M. tuberculosis
PLOS ONE | www.plosone.org 5 February 2013 | Volume 8 | Issue 2 | e56037
glycolytic pathway in M. tuberculosis during aerobic growth with no
functional redundancy with PFKB.
PFKA is not required for virulence and survival in the
mouse model of tuberculosis infection
Genes encoding putative disaccharide transporters were pre-
dicted to be required for the first week of mouse infection [10].
Studies in Salmonella enterica serovar Typhimurium have shown that
PFK is important during mouse infection [14,15]. To study the
role of PFKA in M. tuberculosis virulence, BALB/c mice were
nasally infected with the parental or DpfkA strains, and their
infection profiles in the lung and spleen were monitored. The
results indicated that the bacterial loads in both organs recovered
from both mouse groups were comparable (Fig. 6). This result thus
suggested that PFKA, and therefore glycolysis, is not crucial for M.
tuberculosis survival and persistence in the mouse lungs and spleen.
This result does not rule out the possibility that PFKA may be
required for survival in other animal models where pathology and
physiology of the bacterium are closer to those observed during
human infection.
PFKA is required for survival of hypoxic non-replicating
M. tuberculosis
During the course of in vitro aerobic growth we noticed that
DpfkA mutant displayed impaired fitness upon reaching stationary
phase in Dubos medium with no visible signs of clumping (Fig. 7A).
Dubos medium contains large amount of glucose, amino acids and
lipids as main sources of carbon and energy. When glucose was
depleted from the Dubos medium, DpfkA mutant survived as well
as the parental strain during the stationary phase (Fig. 7B). We
thus hypothesized that accumulation of toxic glucose-derived
sugar-phosphates such as glucose-6-phospate and fructose-6-
phosphate in the DpfkA mutant may account for the growth defect
observed during co-metabolism when oxygen tension becomes
limiting. Sugar-phosphates have indeed been shown to be highly
toxic in many bacteria, including M. tuberculosis [28]. Consistently,
the pool of glucose-6-phospate and fructose-6-phosphate measured
during the exponential growth of the DpfkA mutant was 50%
higher compared to the parental strain (Table 3). It is interesting to
note that while accumulation of sugar-phosphates occurs during
the growth exponential phase, the toxic phenotype instead was
only observed during the stationary phase, linking the detrimental
effect of sugar-phosphate accumulation with oxygen depletion.
This observation prompted us to extend our study to the
survival of DpfkA mutant under anaerobic conditions using the
well-established in vitro Wayne model of hypoxia in which gradual
depletion of oxygen triggers the bacterium to enter a non-
replicating state [27]. In this model, Dubos medium supplemented
with glucose is classically employed by the vast majority of
research groups to study the physiology of hypoxic non-replicating
mycobacteria [27]. The DpfkA mutant multiplied efficiently before
oxygen depletion. However after day 6, which coincided with
decolourization of the oxygen probe methylene blue, DpfkA
bacteria displayed a significant viability loss compared to the
parental and complemented strains (Fig. 7C). To test whether the
attenuated phenotype was linked to the accumulation of toxic
glucose-derived metabolites, the same experiment was performed
in culture medium in which addition of glucose was omitted. In
these culture conditions DpfkA mutant survived as well as the
parental strain, demonstrating that in the presence of exogenous
glucose, absence of PFK activity leads to the accumulation of toxic
metabolic intermediates in hypoxic non-replicating mycobacteria
(Fig. 7D).
Glucose is detrimental for long term M. tuberculosis
survival in the Wayne model
The toxic effect of glucose observed in the Wayne model when
the glycolytic pathway is disrupted prompted us to take a closer
look at the limited viability traditionally observed with M.
tuberculosis whereby non-replicating mycobacteria do not survive
longer than 25 days after which they start to die at an accelerated
rate with less than 0.1% of the initial inoculum of non-replicating
Table 2. pfkA encodes a functional phosphofructokinase.




DpfkA complemented with pfkA 7.3/7.4
DpfkA complemented with pfkB nd/nd
‘His-PFKA 25.062.4 (nmol min21 purified protein mg21)
‘His-PFKB 1.760.02 (nmol min21 purified protein mg21)
Fructose-6-phosphate kinase activity of cell-free extracts from M. tuberculosis strains was measured by coupling fructose-1,6-bisphosphate formation to oxidation of
NADH with aldose, triosephosphate isomerase and a-glycerophosphate dehydrogenase. Each biological sample was measured in duplicate. The data represent the
values obtained for each duplicate of each biological sample. ‘ Enzymatic assay of purified recombinant His-tagged PFKA and His-tagged PFKB of M. tuberculosis was
performed in triplicates and results are expressed as mean 6 SD. Each experiment was repeated as least once independently and comparable values and trends were
observed. Legend: nd, not detectable.
doi:10.1371/journal.pone.0056037.t002
Figure 3. Western blot analysis of PFKB expression in wild-type
M. tuberculosis and mutants. (A) Detection of PFKB with rabbit-anti-
PFKB antibodies. (B) Ponseus-S stained of the membrane showing equal
loading of cell-free extracts. Lane 1: WT; 2: DpfkB ; 3: pfkB-
complemented DpfkA; 4: DpfkA ; 5: purified His-PFKB as control.
doi:10.1371/journal.pone.0056037.g003
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cells still viable at day 40 [27]. While the reason for this limited
long term viability has never been investigated, we hypothesized
that this phenomenon might be explained by the accumulation of
glucose-derived toxic metabolites over time. Consistently, when
grown in medium without glucose, M. tuberculosis viability was
maintained over 60 days, whereas a steep decrease in viability was
observed in the presence of glucose (Fig. 8) as reported before.
Furthermore, analysis of the intracellular metabolites pool showed
significantly higher level of glucose-6-phosphate in hypoxic cells
compared to non-hypoxic bacteria (Table 4). More importantly
the level of glucose-6-phosphate in cells cultured in the glucose-
supplemented medium was 2-fold higher than that in cells cultured
in absence of glucose. Interestingly, the rate of methylene blue
decolourization in culture without glucose was significantly slower
than that observed in culture with glucose, suggesting that the rate
of respiration in M. tuberculosis is slower in the absence of active
glycolysis. Altogether, these observations thus indicate that long-
term survival of hypoxic mycobacteria in the presence of
exogenous glucose is limited by accumulation of toxic glucose-
derived metabolic intermediates.
Discussion
M. tuberculosis is believed to encounter a range of different
microenvironments in its host as it progresses from the initial
infection of alveolar macrophages to the development of
granulomas and extra-pulmonary dissemination. One way that
M. tuberculosis copes with the challenge of changing and hostile
environments is by metabolic adaptation. M. tuberculosis is able to
utilize a variety of carbon sources at least in vitro and genomic
analysis has revealed the presence of a number of carbon
metabolic pathways, including the highly conserved glycolytic
pathway. Previous study has shown the presence of a functional
Figure 4. Phenotypic complementation of DpfkADpfkB E. coli mutant with mycobacterial pfkA and pfkB. (i) DpfkADpfkB E. coli RL257, (ii)
RL257 complemented with Mtb pfkA, (iii) RL257 complemented with Mtb pfkB and (iv) RL257 transformed with empty vector were grown on M9
minimal agar supplemented with (A) 0.2% glucose, (B) 0.2% glucose and IPTG and (C) glycerol.
doi:10.1371/journal.pone.0056037.g004
Figure 5. In vitro growth kinetic of DpfkA and DpfkBmutants on various carbon sources. Growth in liquid medium with glucose, glycerol or
acetate as sole carbon source (as indicated) was monitored for Wild-type, DpfkA, DpfkA complemented with pfkA, DpfkA complemented with pfkB,
and DpfkB M. tuberculosis strains (as indicated). Bacterial growth was monitored by OD absorbance at 600 nm over time. Results are representative of
at least two independent experiments.
doi:10.1371/journal.pone.0056037.g005
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glucose kinase which phosphorylates glucose to glucose-6-phos-
phate (Fig. 1) [29]. Here we demonstrated the presence in M.
tuberculosis H37Rv of a phosphofructokinase (PFK) activity, the key
regulatory enzyme of glycolysis. Similar to E. coli, two mycobac-
terial genes were annotated as PFK encoding genes, namely pfkA
and pfkB. In E. coli PFKB is a minor isoenzyme and accounts for
about 10% of the bacterial PFK activity [30]. Furthermore, a pfkA-
deleted E. coli mutant was shown to be able to grow on glucose
provided that PFKB was present and functional [24,31]. Here, we
have generated strong experimental evidence supporting that
PFKA accounts for the total M. tuberculosis PFK activity without
functional redundancy with PFKB. No PFK activity was detected
in crude extract from DpfkA M. tuberculosis mutant; the DpfkA M.
tuberculosis mutant could not be complemented with pfkB expressed
under a constitutive strong promoter; a PFK-deficient E. coli
mutant could be complemented when expressing M. tuberculosis
pfkA but not M. tuberculosis pfkB; purified recombinant M. tuberculosis
PFKA displayed a PFK activity in vitro while PFKB showed
minimal activity. Although purified recombinant PFKB catalyzes
fructose-6-phosphate in vitro, albeit at very low efficiency, it is not
able to complement the loss of PFKA in vivo. This suggests that
fructose-6-phosphate might not be the true substrate of M.
tuberculosis PFKB. Predictive three-dimensional protein structure
generated by Phyre2 server [32] showed that M. tuberculosis PFKB
shares 40% identity with E. coli PFKB (data not shown). Based on
the presence of the conserved catalytic motif GXGD in its amino
acid sequence, M. tuberculosis PFKB has been classified as a
member of the ribokinase superfamily, PFKB subfamily. Analysis
of T. gondii adenosine kinase’s crystal structure suggested that
enzymes from the ribokinase family are able to adapt easily to a
variety of sugar-based substrates [33]. Members of the PFKB
subfamily which share high degree of structural conservation have
been shown to phosphorylate a variety of substrates beside
fructose-6-phosphate; examples are fructose-1-phosphate in E. coli
Figure 6. Infection profile of DpfkAmutant in mouse. 8-weeks old female BALB/c mice were nasally infected with the wild-type (black circle) or
DpfkA (open circle) strains. Four animals per time point per group were used. Bacterial loads in lung (A) and spleen (B) were determined by CFU
counts. Data are expressed in Log10 CFU per organ as the mean 6 SD of four mice per group.
doi:10.1371/journal.pone.0056037.g006
Figure 7. Growth kinetic of DpfkA mutant under aerobic or hypoxic conditions. Growth in aerobic (A, B) or hypoxic (Wayne model) (C, D)
conditions was monitored over time for wild-type (open circle), DpfkA (open square) and complemented DpfkA (black triangle) strains as determined
by OD600 nm (A, B) or CFU counts (mean6 SD of triplicates) (C, D) in Dubos medium with (A, C) or without (B, D) glucose. Results are representative of
at least two independent experiments.
doi:10.1371/journal.pone.0056037.g007
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[34,35] and tagatose-6-phosphate in S. aureus [36] and E. coli,
although with a lower efficacy than fructose-6-phosphate [37].
Thus, it is possible that M. tuberculosis PFKB is able to
phosphorylate sugar-based substrates other than fructose-6-phos-
phate. So far none of the studies on the kinases from the PFKB
subfamily have identified amino acid residues involved in substrate
specificity. As such the nature of the M. tuberculosis PFKB substrate
cannot be deduced from its amino acid sequence and has yet to be
elucidated.
Co-metabolism experiments showed a defect in cell viability
with DpfkA mutant upon entry into the stationary phase. The
attenuation phenotype was correlated with accumulation of toxic
metabolic intermediates in the glycolytic pathway upstream of
PFKA. Consistently, removal of glucose from the culture medium
restored viability of the DpfkA mutant. Significantly higher
intracellular pools of glucose-6-phosphate and fructose-6-phos-
phate in the DpfkA mutant, compared to the parental strain,
further supports the hypothesis that these sugar-phosphates may
be toxic to the bacterial cell and accumulate in a PFK-deficient
mutant. This finding is consistent with a previous study where we
showed that excessive metabolic intermediates such as glycerol
phosphate, dihydroxyacetone phosphate and methylglyoxal are
toxic to M. tuberculosis [28]. Accumulation of sugar-phosphate may
have various physiological consequences including mRNA desta-
bilization [38], stimulation of gene expression [39], and activation
of pyruvate kinase [40], all of which may contribute to impair the
cell viability. The toxic effect of sugar-phosphate in M. tuberculosis
was previously reported whereby accumulation of maltose-1-
phosphate leads to bacterial death in vitro and in mice [41]. It is of
interest to note that maltose-1-phosphate is a product of trehalose
catabolism with glucose-6-phosphate being a precursor of treha-
lose, thereby linking glycolysis and trehalose pathway. In addition
to the accumulation of toxic metabolic intermediates, the impact
of glycolysis disruption on other metabolic pathways may also play
a role in reduced cell viability. Also, it must be noticed that the
DpfkA mutant did not exhibit significant growth defect in standard
7H9 medium including during the stationary phase (data not
shown). This discrepancy between Dubos and 7H9 media may be
attributed to the higher concentration of glucose in Dubos
medium compared to 7H9 (0.75% versus 0.2%), with the idea
that a threshold glucose concentration may be necessary before a
toxic effect can be observed. However, other differences in the
composition between both media may also explain the difference
in the phenotype observed.
Interestingly, a detrimental effect of glucose was observed in
wild-type M. tuberculosis grown in vitro under hypoxia in the well-
established Wayne model. We showed that M. tuberculosis could
persist in a non-replicating state for much longer when glucose was
omitted in the culture medium. There has been much speculation
on the possible reasons of the limited persistence of M. tuberculosis
in the NRP2 phase of the Wayne model, such as nutrients
exhaustion or low levels of ATP. Here we show that the limited
mycobacterial persistence is linked to the presence of glucose in the
medium and is likely due to the accumulation of glucose-derived
toxic metabolic intermediates. We believe that this finding is of
great importance and advocates for revisiting the mechanisms
employed by M. tuberculosis for long-term persistence in the absence
of growth.
The metabolomic profile of M. tuberculosis infected murine
tissues was recently analyzed and revealed that the level of glucose
and glycogen in those tissues decreased along with the increase in
phospholipids level [42]. This may suggest that M. tuberculosis
switches from the carbohydrate to lipid metabolism in order to
adapt to its microenvironment. However, we did not observe any
significant difference between the DpfkA and parental strains in
their ability to colonize and persist in the mouse lungs and spleen.
This suggests that the glycolytic pathway is dispensable during
mice infection and also indicates that the toxic effect observed in
vitro in Dubos medium is not observed in vivo. It is therefore
possible that M. tuberculosis replicates and persists in an environ-
ment where access to glucose is limited. Alternatively, since
attenuation of the DpfkA mutant was seen mostly under hypoxia in
vitro, absence of hypoxic granuloma or lesions in mice may not
allow recapitulating such attenuation [43]. It would be interesting
to determine the fitness of DpfkA mutant in animal models where
hypoxic granulomatous lesions are formed. Regardless, the
Table 3. Concentration of intracellular glucose-6-phosphate and fructose-6-phosphate in aerobic M. tuberculosis strains.
Glucose-6-phosphate (mmol crude protein g21) Fructose-6-phosphate (mmol crude protein g21)
Glucose + 2 + 2
WT 31.1/29.8 19.3/18.5 7.9/6.4 2.6/1.9
DpfkA 55.0/55.1 32.8/31.3 14.2/13.9 3.7/3.8
Concentration of intracellular metabolites of mid-log phase M. tuberculosis strains cultured in complete Dubos liquid medium or Dubos liquid medium without glucose.
Each biological sample was measured in duplicate. The data represent the values obtained for each duplicate of each biological sample. This experiment was repeated
as least once independently and comparable values and trends were observed.
doi:10.1371/journal.pone.0056037.t003
Figure 8. Growth kinetic of M. tuberculosis H37Rv under
hypoxia in the presence or absence of glucose. Growth under
hypoxia (Wayne model) of wild-type M. tuberculosis was monitored by
determining the number of CFU at various time-point up to Day 60 in
the presence (black square) or absence (open square) of glucose. Data
are expressed as mean 6 SD of triplicates. Results are representative of
two independent experiments. Arrow heads mark the start of
decolourization of methylene blue and full arrows mark the complete
decolourization of methylene blue in culture medium with (black) or
without (red) glucose.
doi:10.1371/journal.pone.0056037.g008
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maintenance of an intact glycolytic pathway in M. tuberculosis
throughout evolution indicates that glycolysis could play an
important role in mycobacterial infection and persistence in
microenvironments not recapitulated in mice.
In conclusion, we provide here the experimental evidence that
PFKA is responsible for the overall PFK activity in M. tuberculosis
and that there is no functional redundancy with PFKB.
Furthermore, our work demonstrates that in the presence of
exogenous glucose, hypoxic mycobacteria tend to accumulate
toxic glucose-derived metabolic intermediates that impair the
bacilli long-term survival. Disruption of the glycolytic pathway
further accentuates accumulation of these toxic intermediates.
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